Our results showed that the positive rate for CCND2 mRNA expression was 41% and the high expression of CCND2 mRNA was negatively correlated with prognosis in ABC-DLBCL patients receiving R-CHOP (P = 0.005). This evidence concerns the gene CCND2 and diffuse large B-cell lymphoma.